Inventor
Birgit Bramlage
Inventor
Kulmbach, DE
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes21%
C07HSugars7%
A01KAnimal husbandry4%
C12YEnzymes4%
B82YSpecific uses or applications of nanostructures1%
C07KPeptides1%
PatentTitleYear
10,619,160Compositions and methods for inhibiting expression of RRM2 genes202010,501,742Compositions and methods for inhibiting expression of the PCSK9 gene20199,938,531Compositions and methods for inhibiting expression of RRM2 genes20189,822,365'Compositions and methods for inhibiting expression of the PCSK9 gene'20179,260,718'Compositions and methods for inhibiting expression of the PCSK9 gene'20169,050,375'Bi-specific digoxigenin binding antibodies'20159,012,624'Compositions and methods for inhibiting expression of a gene from the JC virus'20158,946,176'Compositions and methods for inhibiting expression of RRM2 genes'20158,809,292'Compositions and methods for inhibiting expression of the PCSK9 gene'20148,410,261'Compositions and methods for inhibiting expression of a gene from the JC virus'20138,314,075'Compositions and methods for inhibiting expression of huntingtin gene'20128,222,222'Compositions and methods for inhibiting expression of the PCSK9 gene'20128,124,752'Compositions and methods for inhibiting expression of the MYC gene'20128,114,984'RNAi modulation of Aha and therapeutic uses thereof'20128,080,532'Compositions and methods for inhibiting expression of Huntingtin gene'20118,058,257'Compositions and methods for inhibiting expression of a gene from the JC virus'20117,956,177'dsRNA compositions and methods for treating HPV infection'20117,812,150'RNAi modulation of Aha and therapeutic uses thereof'20107,749,978'Compositions and methods for inhibiting expression of Huntingtin gene'20107,737,265'RNAi modulation of HIF-1 and therapeutic uses thereof'20107,691,824'Compositions and methods for inhibiting expression of a gene from the JC virus'20107,605,251'Compositions and methods for inhibiting expression of the PCSK9 gene'20097,320,965'Compositions and methods for inhibiting expression of Huntingtin gene'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2019Patents assigned to ALNYLAM PHARMACEUTICALS INC (18)· patent assignee history
2008–2019Based in Kulmbach, DE· patent location history
2011–2015Patents assigned to BRAMLAGE BIRGIT (10)· patent assignee history
2011–2014Patents assigned to TAN PAMELA (8)· patent assignee history
2011–2012Patents assigned to BUMCROT DAVID (3)· patent assignee history
2011–2012Patents assigned to VORNLOCHER HANS-PETER (3)· patent assignee history
2013Based in Kulmback, DE· patent location history
2018–2020Based in Meggen, CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 18 | 2008–2019 |
| BRAMLAGE BIRGITself | 10 | 2011–2015 |
| TAN PAMELA | 8 | 2011–2014 |
| BUMCROT DAVID | 3 | 2011–2012 |
| VORNLOCHER HANS-PETER | 3 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kulmbach, DE | 20 | 2008–2019 |
| Meggen, CH | 2 | 2018–2020 |
| Kulmback, DE | 1 | 2013 |